TNF receptor 1-dependent β cell toxicity as an effector pathway in autoimmune diabetes

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4598-4605

  Kägi, David ^a   Ho, Alexandra ^a   Odermatt, Bernhard ^b   Zakarian, Arsen ^a   Ohashi, Pamela S ^a   Mak, Tak W ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; EFFECTOR CELL; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; MEDIATOR RELEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SPLEEN; TRANSGENES;

EID: 0033561630     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Steinman, L. 1995. Escape from "honor autotoxicus:" pathogenesis and treatment of autoimmune disease. Cell 80:7.
2. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291.
3. Vyse, T. J., and J. A. Todd. 1998. Genetic analysis of autoimmune diseases. Cell 85:311.
4. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese diabetic strain of mice. Exp. Anim. 29:1.
5. Jarpe, A. J., M. R. Hickman, J. T. Anderson, W. E. Winter, and A. B. Peck. 1991. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitits for type I diabetes. Regul. Immunol. 3:305.
6. Wong, F. S., I. Visintin, L. Wen, R. A. Flavell, and C. A. Janeway. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67.
7. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663.
8. Nagata, M., K. Yokono, M. Kayakawa, Y. Kawase, N. Hatamori, W. Ogawa, K. Yonezawa, K. Shii, and S. Baba. 1989. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J. Immunol. 143:1155.
9. + lymphocytes in autoimmune disease: studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J. Immunol. 143:3994.
10. Kägi, D., B. Odermatt, P. Seiler, R. M. Zinkernagel, T. W. Mak, and H. Hengartner. 1997. Reduced incidence and delayed onset of diabetes in perforin-deflcient NOD mice. J. Exp. Med. 186:989.
11. Kägi, D., B. Odermatt, P. S. Ohashi, R. M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143.
12. Stassi, G., M. Todaro, P. Richiusa, M. Giordano, A. Mattina, M. S. Sbriglia, A. Lo Monte, G. Buscemi, A. Galluzo, and C. Giordano. 1995. Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human β cells sorted by flow cytometry and cultured in vitro. Transplant. Proc. 27:3271.
13. Yamada, K., N. Takane-Gyotoku, X. Yuan, F. Ichikawa, C. Inada, and K. Nonaka. 1996. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306.
14. Chervonsky, A. V., Y. Wang, S. Wong, I. Visintin, R. Flavell, C. A. Janeway, and L. A. Malis. 1997. The role of Fas in autoimmune diabetes. Cell 89:17.
15. Bradley, B. J., K. Haskins, F. G. La Rosa, and K. J. Lafferty. 1992. CD8 T cells are not required for islet destruction induced by a CD4-positive islet-specific T cell clone. Diabetes 41:1603.
16. Shehadeh, N. N., and K. J. Lafferty. 1993. The role of T-cells in the development of autoimmune diabetes. Diabetes Rev. 1:141.
17. Katz, J. D., and C. Benoist. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
18. Bendtzen, K., T. Mandrup-Poulsen, J. Nerup, J. H. Nielsen, C. A. Dinarello, and M. Svenson. 1986. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545.
19. Mandrup-Poulsen, T., K. Bendtzen, C. A. Dinarello, and J. Nerup. 1987. Human necrosis factor potentiates human interleukin-1 mediated rat pancreatic β cell cytotoxicity. J. Immunol. 139:4077.
20. Campbell, I. L., A. Iscaro, and L. C. Harrison. 1988. IFN-γ and tumor necrosis factor-α cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325.
21. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
22. Held, W., H. R. MacDonald, I. L. Weissman, M. W. Hess, and C. Müller. 1990. Genes encoding tumor necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 87:2239.
23. Müller, C., W. Held, M. A. Imboden, and C. Carnaud. 1995. Accelerated β cell destruction in adoptively transferred autoimmune diabetes correlates with an increased expression of the genes coding for TNFα and granzyme A in the intraislet infiltrates. Diabetes 44:112.
24. Dahlén, E., K. Dawe, L. Ohlsson, and G. Hedlund. 1998. Dendritic cells and macrophages are the first and major producers of TNF-α in pancreatic islets in the nonobese diabetic mouse. J. Immunol. 160:3585.
25. Yang, X.-D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995.
26. Satoh, J., H. Seino, T. Abo, S.-I. Tanaka, S. Shintani, S. Ohta, K. Tamura, T. Sawai, T. Nobunaga, T. Oteki, et al. 1989. Recombinant human tumor necrosis factor-α suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84:1345.
27. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA 87:968.
28. Higuchi, Y., P. Herrera, P. Muniesa, J. Huarte, D. Belin, P. S. Ohashi, P. Aichele, L. Orci, J.-D. Vassalli, and P. Vassalli. 1992. Expression of a tumor necrosis factor a transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719.
29. McSorley, S. J., S. Soldera, L. Malherbe, C. Carnaud, R. M. Locksley, R. A. Flavell, and N. Glaichenhaus. 1997. Immunological tolerance to a pancreatic antigen as a result of local expression of TNFα by islet β cells. Immunity 7:401.
30. Pfeffer, K., T. Matsuyama, T. M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Krönke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
31. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. M. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
32. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: development during the last decade. Eur. Cytokine Netw. 7:93.
33. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
34. Ohashi, P. S., S. Oehen, K. Bürki, H. P. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
35. McKall-Faienza, K. J., K. Kawai, T. M. Kündig, B. Odermatt, M. F. Bachmann, A. Zakarian, T. W. Mak, and P. S. Ohashi. 1998. Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocyte infiltration. Int. Immunol. 10:101.
36. Ghosh, S., S. M. Palmer, N. R. Rodrigues, H. J. Cordell, C. M. Hearne, R. J. Cornall, J.-B. Prins, P. McShane, G. M. Lathrop, L. B. Peterson, et al. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4:404.
37. McAleer, M. A., P. Reifsnyder, S. M. Palmer, M. Prochazka, J. M. Love, J. B. Copeman, E. E. Powell, N. R. Rodrigues, J.-B. Prins, D. V. Serreze, et al. 1995. Crosses of NOD mice with the related NON strain: a polygenic model for IDDM. Diabetes 44:1186.
38. Whitton, J. L., J. R. Gebhard, H. Lewicki, A. Tishon, and M. B. Oldstone. 1988. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 62:687.
39. Hany, M., S. Oehen, M. Schulz, H. Hengartner, M. Mackett, D. H. L. Bishop, and R. M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunisation with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol 19:417.
40. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 312:548.
41. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
42. Goodwin, R., D. Anderson, R. Jerry, T. Davis, C. I. Brannan, N. G. Copeland, N. A. Jenkins, and C. A. Smith. 1991. Molecular cloning and expression of the type I and type 2 murine receptors for tumor necrosis factor. Mol. Cell. Biol. 11:3020.
43. Miazaki, A., T. Hanafusa, K. Yamada, I. Miyagawa, H. Fujino-Kurihara, H. Nakajima, K. Nonaka, and S. Tarui. 1985. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 60:622.
44. Harada, M., and S. Makino. 1984. Promotion of spontaneous diabetes in nonobese diabetic-prone mice by cyclophosphamide. Diabetologia 37:604.
45. Picarella, D. E., A. Kratz, C.-B. Li, N. H. Ruddle, and R. A. Flavell. 1992. Insulitis in transgenic mice expressing tumor necrosis factor β (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89:10036.
46. Picarella, D. E., A. Kratz, C.-B. Li, N. H. Ruddle, and R. A. Flavell. 1993. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis not diabetes. J. Immunol. 150:4136.
47. Grewal, I. S., K. D. Grewal, F. S. Wong, D. E. Picarella, C. A. Janeway, and R. A. Flavell. 1996. Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184:1963.
48. Vieira, L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157: 827.
49. -1- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7:419.
50. Shalaby, M. R., T. Espevik, G. C. Rice, A. J. Ammann, I. S. Figari, G. E. Ranges, and M. A. Palladino. 1988. The involvement of human necrosis factor-α and -β in the mixed lymphocyte reaction. J. Immunol. 141:499.
51. Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias. 1997. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94: 6319.
52. Zheng, L., G. Fischer, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
53. Speiser, D. E., E. Sebzda, M. F. Bachmann, K. Pfeffer, T. W. Mak, and P. S. Ohashi. 1996. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26:3055.
54. Sytwu, H. K., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/Apo-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
55. Zhou, T., C. K. Edwards, P. Yang, Z. Wang, H. Bluethmann, and J. D. Mountz. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor. J. Immunol. 156:2661.
56. Pukel, H., H. Baquerizo, and A. Rabinovitch. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumour necrosis factor, lymphotoxin and interleukin 1. Diabetes 37:133.
57. Sarukhan, A., A. Lanoue, A. Franzke, N. Brousse, J. Buer, and H. von Boehmer. 1998. Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J. 17:71.
58. Bottazzo, G. F., B. M. Dean, J. M. McNally, E. H. MacKay, P. G. F. Swift, and D. R. Gamble. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313:353.
59. Sibley, R. K. 1985. Recurrent diabetes mellitus in the pancreas iso-and allograft: a light and electron microscopic analysis of four cases. Lab. Invest. 53:132.